MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive: In vitro studies have shown that induction of p53 through MDM2 inhibition by the small-molecules such as Nutlins and MI219 effectively induces p53-mediated apoptosis in most blast crisis CML cells, with or without mutations including T315I variant [18, 19].